Critical appraisal of bevacizumab in the treatment of ovarian cancer
Hiroyuki Yoshida, Akira Yabuno, Keiichi FujiwaraDepartment of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, JapanAbstract: Bevacizumab is the first molecular-targeted agent to be used for the treatment of ovarian cancer. Bevacizumab is a humanized mo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/critical-appraisal-of-bevacizumab-in-the-treatment-of-ovarian-cancer-peer-reviewed-article-DDDT |